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Enhanced Beta-Adrenergic Response, Spontaneous Calcium Release, and
Arrhythmogenic Propensity in Mice with a Phosphomimetic Mutation of
a PKA Site (S2030D) in the Cardiac Ryanodine Receptor
Qiang Zhou, Yijun Tang, Ruiwu Wang, S.R. Wayne Chen.
University of Calgary, Calgary, AB, Canada.
The phosphorylation of the cardiac calcium release channel/ryanodine re-
ceptor (RyR2) by protein kinase A (PKA) has been extensively investigated,
but its functional consequences remain poorly understood and controversial.
We have previously shown that S2030 is a major PKA site in RyR2 re-
sponding to beta-adrenergic stimulation, and that phosphomimetic mutation
of this PKA site (S2030D) enhances luminal calcium activation of single
RyR2 channels and increases the propensity for spontaneous calcium release
in HEK293 cells during store calcium overload. To further investigate the
physiological and pathophysiological significance of PKA phosphorylation
of S2030, we generated a knock-in mouse model harboring the phosphomi-
metic S2030D mutation in RyR2. We found that S2030D mutant mice dis-
played higher isoproterenol-induced heart rate increase than wt mice. ECG
recordings revealed that S2030D mutant mice were more susceptible to bi-
directional ventricular tachycardia induced by the injection of epinephrine
plus caffeine as compared to wt mice. To determine the impact of the
S2030D mutation on sarcoplasmic reticulum (SR) calcium handling, ventric-
ular myocytes isolated from wt and mutant mice were loaded with fluo-4
and field-stimulated. Calcium imaging showed that S2030D mutant cells ex-
hibited enhanced spontaneous calcium release activity in the presence of
isoproterenol. These observations indicate that the S2030D mutation in
RyR2 enhances the beta-adrenergic response, and suggest that excessive
PKA phosphorylation of S2030 in RyR2 may increase the propensity for
stress-induced spontaneous SR calcium release and ventricular arrhythmias
(supported by CIHR).
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Mice Expressing Heterozygous and Homozygous RyR1-T4826I Mutation
Reveal Gender-Dependent Phenotypic Penetrance to MH Triggering
Agents and Altered Temperature Regulation Following Glucose Challenge
Benjamin T. Yuen1, Genaro Barrientos1, Diptiman D. Bose1,
Tianzhong Yang2, Samuel R. Goth1, Paul D. Allen2, Isaac N. Pessah1.
1University of California, Davis, VM: Molecular Biosciences, Davis,
CA, USA, 2Bringham and Women’s Hospital, Anesthesiology, Boston,
MA, USA.
MH is an adverse reaction to general anesthetics characterized by increased
temperature, muscle rigidity, general metabolic acidosis, and is fatal if left un-
treated. Knock-in mice expressing either heterozygous (HET) or homozygous
(HOM) human MH mutation RyR1-T4826I are fully viable under typical rear-
ing conditions. HOMmice trigger within 20 min of heat stress (40C) or within
40 min of exposure to halothane (2%y37C), whereas HET mice do not. All
HET males exposed to a single halothane anesthetic (2%y40C) trigger with
MH, whereas up to 50% of the females survive multiple anesthetics. Fasted
mice were challenged with glucose i.p., and glucose uptake rates measured.
Our results indicate that at 23C, HOM and WT males exhibit similar glucose
uptake, whereas HOM females displayed lower glucose uptake than their WT
counterparts (regardless of gender, n ¼ 4). However, at 30C, HOM males and
females exhibit enhanced glucose uptake compared to corresponding WT (n ¼
4). WT male and female animals maintain stable temperatures during testing,
whereas HOMmice show an inverse relationship (decreasing body temperature
with increasing blood glucose following challenge). MH mutation RyR1-
T4826I confers genotype- and gender-dependent susceptibility to triggering.
These data reveal that RyR1-T4826I mice have pronounced metabolic impair-
ments that may contribute to the fulminant MH response. Supported by NIH
AR43140 and AR52354.
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Role of Oxidative Stress, Autophagy and Apoptosis in the I4895T RyR1
Knockin Mice
Aditya D. Joshi, Ruirui Ji, Jianjun Xu, Cheng Long, Susan L. Hamilton.
Baylor College of Medicine, Houston, TX, USA.
I4898T mutation in the skeletal muscle ryanodine receptor (RyR1) in humans
has been suggested to underlie Central Core Disease (CCD). CCD is the con-
genital myopathy characterized by muscle weakness of lower extremities lead-
ing to delayed attainment of motor skill milestones. We created mice with
a corresponding RyR1 I4895T mutation. Although no central cores were ob-
served in the muscle of these mice, this uncoupling mutation dramatically re-
duces voluntary running. The soleus muscle from the I4895T mice displays
decreased ability to generate force, increased oxidative stress, decreased anti-oxidant capacity and decreased cytochrome c oxidase activity (suggesting
mitochondrial damage). We also find evidence of both autophagy and apopto-
sis in the mutant muscle since Atg5, Atg6 (Beclin1), Atg9, Atg12, Bcl2, cas-
pase family members, C/EBP homologous protein (CHOP) are all upregulated
in the soleus. Upregulation of several ER stress related proteins (BiP, IRE1a,
and PDI) was also observed. We propose that the I4895 mutation is associated
with the oxidative stress, an unfolded protein response (UPR), autophagy and
apoptosis, all of which may contribute to mitochondrial destruction associated
with this disease.
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Does Central Core Disease have a Neuronal Component?
Valerie De Crescenzo1, Kevin E. Fogarty1, Karl D. Bellve´1,
Richard A. Tuft1, Elena Zvaritch2, David H. Maclennan2, John V. Walsh1.
1UMASS med school, Worcester, MA, USA, 2University of Toronto,
Toronto, ON, Canada.
Type 1 ryanodine receptors (RyR1) are the second most common isoform
found in neurons after RyR2. We have provided evidence that in nerve ter-
minals from neurohypophysis, L-type Ca2þ channels are coupled to RyR1
in the same way found in EC coupling in skeletal muscle. In these nerve ter-
minals (J.Neuroscience 2006, 26 7565) L-type channels are the sensors of
membrane potential for Voltage Induced Ca2þ Release (VICaR), indepen-
dently of their role as Ca2þ current carriers, and RyRs of uknown type
are the effectors through which Ca2þ is released into the cytosol. Here
we wished to study whether RyRs of type 1 are mediators of VICaR in these
nerve terminals. We employed a RyR1 mutant mouse (I4895T) with a loss
of function phenotype that causes Central Core Disease in humans. We stud-
ied both, global [Ca2þ] with Fura-2 and focal [Ca2þ] in the form of Ca2þ
syntillas with fluo3. When the nerve terminals were depolarized to 0mV, the
mutant showed a 4-fold decrease in the global Ca2þ transient compared to
WT. This very large decrease in the Ca2þ transient occurred in the absence
of any change in the Ca2þ current. In the absence of external Ca2þ, we also
demonstrated the presence of VICaR in WT. Moreover, in the WT depolar-
ization to 0mV from 80mV induced a 3 fold increase in syntilla frequency
due to VICaR (i.e. in the absence of external Ca2þ). VICaR was totally ab-
sent in the mutant. These data show for the first time the involvement of
type 1 RyRs during depolarization of nerve terminals. This suggests that
Central Core Disease has a neuronal component as well as a skeletal muscle
component.( Supported by grants from NIH GM087580-01 to JW and AHA
0835580D to VD.)
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Functional Role of Mitochondrial Ryanodine Receptor Type 1 in the Heart
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1University of Rochester Medical Center, Rochester, NY, USA, 2Baylor
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We recently demonstrated the existence of type 1 ryanodine receptors (RyR1)
in the mitochondria of cardiac muscle cells (Beutner et al, 2001, 2005, Altschafl
et al, 2007). However, the functional significance of mitochondrial type 1 rya-
nodine receptors (mitoRyR1), especially in the whole heart preparations, re-
mains unclear. We determined the cardiac phenotype of knock-in mice harbor-
ing an RyR1 mutation (RyR1Y522S) that promotes RyR1 Ca2þ leak and results
in malignant hyperthermia and central cores in humans. In Langendorff
perfused hearts, isoproterenol (10-50 nM) infusion induced a significantly
(p<0.01) larger increase in heart rate (HR) and left ventricular end-diastolic
pressure (LVDEP) in RyR1Y522S/ WT mice (HR, 593.15 24.0 / min; LVDEP,
56.2 5 1.5 mmHg) compared with littermate control wild type mice (HR,
518.6 5 11.4/ min; LVDEP, 24.8 5 7.4 mmHg).In anesthetized mice,
electrocardiogram recordings showed isoproterenol-induced arrhythmia and
tachycardia in the RyR1Y522S/WT but not wild type mice (n>8). We studied
the morphology of cardiac mitochondria using electron microscopy. Cardiac
mitochondria in RyR1Y522S/WT mice (3-18 months old) exhibit a lower density
of cristae, a higher incidence of mitochondrial clustering and misalignment
with sarcomeres, and a dissociation of mitochondria from myofilaments,
as routinely observed in controls (n>5). Finally, we examined the heart
structure of homozygous RyR1Y522S/Y522S embryos, which die prior to birth.
Compared to RyR1Y522S/WT and wild-type littermates, RyR1Y522S/Y522S em-
bryos developed normally until approximately embryonic day (E) 14.5, after
which their hearts exhibit significant myocyte disarray, lack ventricular lumen
and display evidence of heart failure. These results are consistent with the hy-
pothesis that mitoRyR1 plays an important role in the proper development and
regulation of cardiac structure and function.
